Etablierung eines präoperativen Anämiemanagements

Zusammenfassung

Rund 30 % aller Patienten leiden an einer präoperativen Anämie, die einen relevanten Risikofaktor für erforderliche Transfusionen, verlängerte Hospitalisierung, gesteigerte Morbidität und Sterblichkeit darstellt. Die Mortalität während des Krankenhausaufenthalts kann bei Patienten mit mittlerer präoperativer Anämie um das Doppelte erhöht sein. Zudem sind intensivpflichtige Zeit und Krankenhausverweildauer deutlich länger. Die Etablierung eines präoperativen Anämiemanagements im Rahmen des Patient Blood Management ist daher eine entscheidende Säule zur Verbesserung des Behandlungsergebnisses und der Patientensicherheit und kann gleichzeitig die Kosten für das Gesundheitswesen signifikant reduzieren.

• Literatur

• 1 World Health Organization. Haemoglobin concentrations for the diagnosis of anaemia and assessment of severity. Vitamin and Mineral Information System. World Health Organization; Geneva, Switzerland: 2011
• 2 Koch CG, Li L, Sun Z. et al. Hospital-acquired anemia: Prevalence, outcomes, and healthcare implications. J Hosp Med 2013; 8: 506-512
• 3 Meybohm P, Schmitz-Rixen T, Steinbicker A. et al. Das Patient-Blood-Management-Konzept. Gemeinsame Empfehlung der Deutschen Gesellschaft für Anästhesiologie und Intensivmedizin und der Deutschen Gesellschaft für Chirurgie. Chirurg 2017; 88: 867-870
• 4 Baron DM, Hochrieser H, Posch M. et al. Preoperative anaemia is associated with poor clinical outcome in non-cardiac surgery patients. Br J Anaesth 2014; 113: 416-423
• 5 Meybohm P. et al. Patient Blood Management in der Intensivmedizin. Intensivmedizin up2date 2017; 13: 291-307
• 6 Musallam KM, Tamim HM, Richards T. et al. Preoperative anaemia and postoperative outcomes in non-cardiac surgery: a retrospective cohort study. Lancet 2011; 378: 1396-1407
• 7 Zindrou D, Taylor KM, Bagger JP. Preoperative haemoglobin concentration and mortality rate after coronary artery bypass surgery. Lancet 2002; 359: 1747-1748
• 8 von Heymann C, Kaufner L, Sander M. et al. Does the severity of preoperative anemia or blood transfusion have a stronger impact on long-term survival after cardiac surgery?. J Thorac Cardiovasc Surg 2016; 152: 1412-1420
• 9 Kassebaum NJ, Jasrasaria R, Naghavi M. et al. A systematic analysis of global anemia burden from 1990 to 2010. Blood 2014; 123: 615-624
• 10 http://www.awmf.org/leitlinien/detail/anmeldung/1/ll/001–024.html
• 11 Government of Western Australia Department of Health. Patient blood management guidelines and standards. http://ww2.health.wa.gov.au/Articles/N_R/Patient-blood-management-guidelines-and-standards
• 12 Muñoz M, Acheson AG, Auerbach M. et al. International consensus statement on the peri-operative management of anaemia and iron deficiency. Anaesthesia 2017; 72: 233-247
• 13 Shah N, Andrews J, Goodnough LT. Transfusions for anemia in adult and pediatric patients with malignancies. Blood Rev 2015; 29: 291-299
• 14 AWMF-S3-Leitlinie Präoperative Anämie. http://www.awmf.org/leitlinien/detail/anmeldung/1/ll/001–024.html
• 15 Auerbach M, Macdougall IC. Safety of intravenous iron formulations: facts and folklore. Blood Transfus 2014; 12: 296-300
• 16 Froessler B, Palm P, Weber I. et al. The Important Role for Intravenous Iron in Perioperative Patient Blood Management in Major Abdominal Surgery: A Randomized Controlled Trial. Annals of Surgery 2016; 264: 41-46
• 17 Meybohm P, Goehring MH, Choorapoikayil S. et al. Feasibility and efficiency of a preoperative anaemia walk-in clinic: secondary data from a prospective observational trial. Br J Anaesth 2017; 118: 625-626
• 18 Khalafallah AA, Yan C, Al-Badri R. et al. Intravenous ferric carboxymaltose versus standard care in the management of postoperative anaemia: a prospective, open-label, randomised controlled trial. The Lancet Haematology 2016; 3: e415-25
• 19 So-Osman C, Nelissen RG, Koopman-van Gemert AW. et al. Patient blood management in elective total hip- and knee-replacement surgery (Part 1): a randomized controlled trial on erythropoietin and blood salvage as transfusion alternatives using a restrictive transfusion policy in erythropoietin-eligible patients. Anesthesiology 2014; 120: 839-851
• 20 Jelkmann I, Jelkmann W. Impact of erythropoietin on intensive care unit patients. Transfus Med Hemother 2013; 40: 310-318
• 21 Duce L, Cooter ML, McCartney SL. et al. Outcomes in Patients Undergoing Cardiac Surgery Who Decline Transfusion and Received Erythropoietin Compared to Patients Who Did Not: A Matched Cohort Study. Anesth Analg. 2017 Aug 29. doi: 10.1213/ANE.0000000000002418. [Epub ahead of print]
• 22 Mesgarpour B, Heidinger BH, Schwameis M. et al. Safety of offlabel erythropoiesis stimulating agents in critically ill patients: a meta-analysis. Intensive Care Med 2013; 39: 1896-1908